CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 1,097 enrolled
Drug / intervention
Carotid WALLSTENT Monorail Endoprosthesis +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00741091
NCT00741091Phase 4Completed

A Carotid Stenting Boston Scientific Surveillance Program Carotid WALLSTENT Monorail Endoprosthesis FilterWire EZ™ Embolic Protection System

Boston Scientific Corporation·interventional·Posted Aug 26, 2008·Updated Aug 24, 2011

In Brief

A Phase 4 clinical trial evaluating Carotid WALLSTENT Monorail Endoprosthesis and FilterWire EZ™ System™ for Carotid Artery Disease. Completed, enrolled 1,097 participants across 112 sites.

Detailed Summary

CABANA is a multicenter U.S. surveillance registry that will be conducted to compile early clinical outcomes data for the Carotid WALLSTENT Endoprosthesis and FilterWire EZ System in routine clinical practice and to assess the adequacy of the Boston Scientific Corporation (BSC) Carotid Stenting Training Program.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedAug 26, 2008
Enrollment StartDec 1, 2008
Primary CompletionOct 1, 2010
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 17.8 years ago

Interventions

Carotid WALLSTENT Monorail Endoprosthesisdevice

A carotid artery stent for use in subjects at high risk for adverse events from Carotid endarterectomy (CEA) due to either anatomic or comorbid conditions who require carotid revascularization in the treatment of ipsilateral or bilateral carotid artery disease.

FilterWire EZ™ System™device

Embolic protection device used in conjunction with the Carotid WALLSTENT Endoprosthesis.